Valuation
P/E Ratio -0,17x
P/B Ratio -0,22x
P/S Ratio —
P/FCF Ratio —
Margins
Gross Margin 13,17 %
Operating Margin -58,29 %
Net Margin -91,90 %
HARTE GOLD CORP Share · CA4161901067 · A0J3QP (XTSE) New York Life · Canada · Basic Materials — real-time prices and quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of HARTE GOLD CORP
No Price
Asset Allocation
| Asset | Percentage % |
|---|---|
| Equity | 88,45 % |
| Other | 11,54 % |
Largest Positions
Updated on May 18 2026, 4:34 PM
| Symbol | ISIN | CUSIP | Name | Shares | Market Value | Percentage % |
|---|---|---|---|---|---|---|
| GOOGL | US02079K3059 | 02079K305 | Alphabet Inc. Class A | 2.594 | 528.916,60 EUR | 5,77 % |
| AAPL | US0378331005 | 037833100 | Apple Inc. | 2.218 | 513.666,62 EUR | 5,61 % |
| JNJ | US4781601046 | 478160104 | Johnson & Johnson | 2.871 | 507.133,44 EUR | 5,53 % |
| AZN.L | GB0009895292 | G0593M107 | AstraZeneca PLC | 3.082 | 484.414,58 EUR | 5,29 % |
| NOVN.SW | CH0012005267 | H5820Q150 | Novartis AG | 3.893 | 480.986,74 EUR | 5,25 % |
| PFE | US7170811035 | 717081103 | Pfizer Inc. | 18.968 | 476.855,52 EUR | 5,20 % |
| UNH | US91324P1021 | 91324P102 | UnitedHealth Group Incorporated | 1.476 | 448.718,76 EUR | 4,90 % |
| ABT | US0028241000 | 002824100 | Abbott Laboratories | 3.336 | 439.518,00 EUR | 4,80 % |
| BSX | US1011371077 | 101137107 | Boston Scientific Corporation | 4.233 | 436.718,61 EUR | 4,77 % |
| LLY | US5324571083 | 532457108 | Eli Lilly and Company | 604 | 423.542,92 EUR | 4,62 % |
Country Distribution
| Country | Percentage % |
|---|---|
| USA | 66,86 % |
| Switzerland | 6,82 % |
| United Kingdom and Northern Ireland | 5,84 % |
| Ireland | 3,81 % |
| Spain | 3,59 % |
| Japan | 2,04 % |
| Thailand | 1,12 % |
| Taiwan | 0,94 % |
| Sweden | 0,52 % |
| Other | 7,95 % |
Sector Distribution
| Sector | Percentage % |
|---|---|
| Healthcare | 62,28 % |
| Technology | 12,58 % |
| Consumer Cyclical | 9,08 % |
| Financial Services | 5,61 % |
| Industrials | 1,62 % |
| Consumer Defensive | 0,87 % |
| Other | 7,95 % |
Industry Distribution
| Industry | Percentage % |
|---|---|
| Drug Manufacturers - General | 25,89 % |
| Medical - Devices | 16,31 % |
| Medical - Healthcare Plans | 7,44 % |
| Software - Application | 5,77 % |
| Consumer Electronics | 5,61 % |
| Apparel - Footwear & Accessories | 4,48 % |
| Banks - Diversified | 3,59 % |
| Medical - Care Facilities | 3,46 % |
| Medical - Pharmaceuticals | 3,14 % |
| Other | 7,95 % |
Currency Distribution
| Currency | Percentage % |
|---|---|
| USD | 76,38 % |
| Unknown | 7,95 % |
| GBP | 5,29 % |
| CHF | 5,25 % |
| EUR | 2,08 % |
| THB | 1,12 % |
| TWD | 0,94 % |
| SEK | 0,52 % |
| JPY | 0,46 % |
Company Profile for HARTE GOLD CORP Share
Harte Gold Corp. engages in the acquisition, exploration, evaluation, development, and mining of mineral resource properties in Canada. The company explores for gold deposits. The company primarily focuses on its 100% owned Sugar Zone property, which consists of 69 boundary cell claims, 43 single cell claims, 197 multi-cell claims, and four mining leases covering an area of approximately 81,287 hectares located in the Sault Ste. Marie Mining Division in Ontario. The company was formerly known as Harte Resources Company and changed its name to Harte Gold Corp. in December 2003. Harte Gold Corp. was incorporated in 1982 and is headquartered in Toronto, Canada.
Fund Master Data
Issuer New York Life
Asset Class ETF
Name IQ Healthy Hearts ETF
Fund Currency USD
Fund Key Figures
Fund Size 6.867,15 USD
Investment Strategy
The investment seeks investment results that correspond (before fees and expenses) generally to the price and yield performance of its underlying index, the IQ Candriam Healthy Hearts Index. The fund employs a passive management - or indexing - investment approach designed to track the performance of the index, which was developed by IndexIQ LLC with Candriam Belgium S.A. acting as index consultant to IndexIQ. The index includes securities of large-, mid- and small-capitalization companies that trade in the U.S. and foreign markets, including emerging markets other than China, Egypt, India, Kuwait, Pakistan, Qatar, Saudi Arabia and United Arab Emirates.
Updated on Aug 21 2021, 12:00 AM
Company Data
Name HARTE GOLD CORP
Company Harte Gold Corp.
Website
https://www.hartegold.com
Primary Exchange 
TSX
TSX
WKN A0J3QP
ISIN CA4161901067
Asset Class Share
Sector Basic Materials
Industry Gold
CEO Sam Coetzer
Country Canada
Currency CAD
Employees 0,1 T
Address 8 King St E Suite 1700, M5J 2S1 Toronto
IPO Date 2000-12-11
Key Ratios
As of 03.07.2026
Ticker Symbols
| Name | Symbol |
|---|---|
| TSX | HRT.TO |